Source: Shutterstock

IRESS has announced that it has added Scottish Widows‘ new income protection (IP) product to The Exchange.

Scottish Widows’ IP product is in addition to the existing Term, Multi-Benefit and Mortgage Protection products on The Exchange.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The Exchange is a the quote and apply platform from Iress.

Iress’s global head of product for sourcing, Jacqui Durbin, said: “As long-standing partners of Scottish Widows, we’re delighted to support its launch into the Income Protection space through our extensive distribution network on The Exchange. It also supports our commitment to offering the broadest range of products to brokers and advisers.”

Scottish Widows’ protection director, Rose St Louis, added: “Our goal is to help people to be better prepared financially if they were not able to work. Our new IP product is the next step on our mission to help people build their financial resilience and make it easier for advisers to serve more of their customers’ needs with a streamlined process and slicker experience through tech partners like Iress.”

In October 2024, IRESS announced that Zurich is the third provider to support its ex-smoker questions on The Exchange sourcing platform.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

By enabling the questions on its Term and Critical Illness products, Zurich will deliver greater upfront accuracy to brokers and their clients during the quotation process.

In addition, the questions will enable Zurich to see between smokers and ex-smokers, allowing for more precise premiums that accurately reflect individual risk profiles.